Analisis Biaya dan Nilai Utilitas pada Pasien Hemodialisis yang Diberikan Terapi Erythropoiesis di Rumah Sakit

Chronic kidney failure is a condition where there gradual decline in function. disease often followed by complications of anemia. The use erythropoietin therapy chronic renal patients undergoing hemodialysis requires no small amount money. This affects the quality life (utility). purpose this study to measure costs and utility values using EQ-5D-5L (EuroQol-Five Dimensions) instrument, VAS (Visual Analog Scale), based on patient's perspective at Prof.Aloei Saboe Hospital. prospective cross-sectional approach. Data was collected EQ-VAS questionnaires. subjects were as many 45 met inclusion criteria. results showed that most widely used Erythropoietin single Hemapo. calculation estimated cost each patient from for one month are Rp. 7,112,000. average expenditure transportation 50,111. food 25,000.Utility value Indonesian set 0.673 (sufficiently feeling well)and score 71.4 (health status quite healthy).